Not applicableEnded earlyNCT00898430
What this trial is testing
Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy
Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 49